In February 2024, the FDA put two Phase II studies of zelnecirnon under a clinical hold after a case of liver failure was deemed potentially related to the drug.
Drugmaker Viatris beat Wall Street estimates for third-quarter profit and revenue on Thursday, helped by strong demand for its new generic asthma and ADHD drugs, among others, sending its shares up 2.
Expressing concern over the decision to hike prices of eight essential drugs by 50 per cent, the Congress on Saturday urged Prime Minister Narendra M ...
Asthma is a condition in which the airways ... especially if you feel your medications aren’t working or you’re using a quick-relief inhaler more often you have any changes in your symptoms ...